+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Metalloendopeptidase EC342415 and not angiotensin-converting enzyme is the main liver bradykinin-inactivating enzyme



Metalloendopeptidase EC342415 and not angiotensin-converting enzyme is the main liver bradykinin-inactivating enzyme



Journal of Hepatology 28(Suppl. 1): 161




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032312028

Download citation: RISBibTeXText


Related references

Metalloendopeptidase EC 342415 is a major bradykinin-inactivating enzyme in the liver. Hepatology 28(4 Part 2): 459A, 1998

Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells. Circulation Research 81(5): 848-856, 1997

Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43(4): 854-859, 2004

Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. Hypertension Research 26(1): 53-58, 2003

Murine Recombinant Angiotensin-Converting Enzyme 2 Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2 Renin-Angiotensin-Aldosteron. 2012

Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries. Hypertension 50(1): 110-115, 2007

Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension 60(3): 730-740, 2012

Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. Shock 43(4): 395-404, 2015

Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism Clinical & Experimental 50(11): 1346-1350, 2001

Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice. American Journal of Physiology 284(6): 969-H1977, 2003

Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors. Biological & Pharmaceutical Bulletin 30(3): 591-594, 2007

High expression of angiotensin-converting enzyme and angiotensin-converting enzyme 2 in preservation injury after liver transplantation in rats. Hepatology Research 39(11): 1118-1124, 2009

Inhibition of angiotensin converting enzyme and potentiation of Bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and Bradykinin. Biochemical Pharmacology. 51(8): 1051-1060, 1996